Cutaneous Myelofibrosis With JAK2 V617F Mutation: Metastasis, Not Merely Extramedullary Hematopoiesis!

被引：11

作者：

Fraga, Garth R. ^{[1
]}

Caughron, Samuel K. ^{[2
]}

机构：

[1] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA

[2] MAWD Pathol Grp, Kansas City, MO USA

来源：

AMERICAN JOURNAL OF DERMATOPATHOLOGY | 2010年 / 32卷 / 07期

关键词：

myelofibrosis; extramedullary hematopoiesis; metastasis; JAK2; leukemia; MYELOID METAPLASIA; IDIOPATHIC MYELOFIBROSIS; SKIN; MANIFESTATION; PATHOGENESIS;

D O I：

10.1097/DAD.0b013e3181d3ca2f

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm. There are 31 reported cases of cutaneous involvement by PMF, most of which have been described as "extramedullary hematopoiesis.'' We report a new case of cutaneous involvement by PMF and demonstrate mutation of the Janus kinase 2 gene in the cutaneous lesions. Extramedullary myelofibrosis is best considered a metastatic phenomenon. Reporting such cases as extramedullary hematopoiesis may cause confusion with reactive forms of extramedullary hematopoiesis.

引用

页码：727 / 730

页数：4

共 50 条

[31] JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome
Lin, Pei
Luthra, Rajyalakshmi
Nussenzveig, Roberto H.
Medeiros, L. Jeffrey
HUMAN PATHOLOGY, 2010, 41 (05) : 758 - 762
[32] The disappearance of two alleles of JAK2 V617F from peripheral blood of a polycythaemia vera patient correlates with transformation into myelofibrosis
Ashur-Fabian, Osnat
Amariglio, Ninette
Cohen, Yoram
Nagler, Arnon
Rechavi, Gideon
Salomon, Ophira
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (06) : 822 - 823
[33] JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia
Li, Juan
Spensberger, Dominik
Ahn, Jong Sook
Anand, Shubha
Beer, Philip A.
Ghevaert, Cedric
Chen, Edwin
Forrai, Ariel
Scott, Linda M.
Ferreira, Rita
Campbell, Peter J.
Watson, Steve P.
Liu, Pentao
Erber, Wendy N.
Huntly, Brian J. P.
Ottersbach, Katrin
Green, Anthony R.
BLOOD, 2010, 116 (09) : 1528 - 1538
[34] Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations
Yang, Hai-Su
CANCER BIOMARKERS, 2016, 17 (04) : 383 - 389
[35] Rapid detection of JAK2 V617F mutation using high-resolution melting analysis with LightScanner platform
Qian, Jun
Lin, Jiang
Yao, Dong-Ming
Chen, Qin
Xiao, Gao-Fei
Ji, Run-Bi
Li, Yun
Yang, Jing
Qian, Zhen
CLINICA CHIMICA ACTA, 2010, 411 (23-24) : 2097 - 2100
[36] The first international meeting on V617F JAK2 mutation and its relevance in Philadelphia-negative myeloproliferative disorders
Kiladjlan, J. J.
Casadevall, N.
Vainchenker, W.
Fenaux, P.
PATHOLOGIE BIOLOGIE, 2007, 55 (02): : 85 - 87
[37] Plasma levels of JAK2 mRNA in patients with chronic myeloproliferative diseases with and without V617F mutation: implications for prognosis and disease biology
Ma, W.
Kantarjian, H.
Zhang, X.
Yeh, C. -H.
Zhang, Z. J.
Verstovsek, S.
O'Brien, S.
Giles, F.
Albitar, M.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2010, 32 (01) : 95 - 102
[38] A resequencing program in India detects the rare JAK2 L579F mutation in patients suffering from polycythemia vera and negative for JAK2 V617F
Acharya, A.
Vaniawala, S.
Parekh, H.
Sheikh, H.
Patel, H.
Ali, R.
Khan, A.
Nagee, A.
Kunjadia, P.
Mukhopadhyaya, P. N.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 (04) : E30 - E33
[39] Is Low Positive JAK2 V617F Mutation Test Result Clinically Significant?: Multi-Institutional Study
Wu, Xiaojun
Lee, Joong Won
Peker, Deniz
Spitzer, Silvia G.
Laser, Jordan
Reddy, Vishnu V. B.
Harada, Shuko
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (08) : 589 - 594
[40] Impact of JAK2 V617F Mutation on Hemogram Variation in Patients with Non-Reactive Elevated Platelet Counts
Zhou, Juan
Ye, Yuanxin
Zeng, Shugen
Zhou, Yi
Mao, Zhigang
Song, Xingbo
Ying, Binwu
Lu, Xiaojun
Jiang, Hong
Wang, Lanlan
PLOS ONE, 2013, 8 (02):

← 1 2 3 4 5 →